Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Revenue (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Revenue for 5 consecutive years, with -$302000.0 as the latest value for Q2 2025.

  • For Q2 2025, Revenue rose 24.69% year-over-year to -$302000.0; the TTM value through Dec 2025 reached -$649000.0, up 18.98%, while the annual FY2023 figure was $7.0 million, N/A changed from the prior year.
  • Revenue hit -$302000.0 in Q2 2025 for Kezar Life Sciences, up from -$347000.0 in the prior quarter.
  • Across five years, Revenue topped out at $7.0 million in Q3 2023 and bottomed at -$401000.0 in Q2 2024.
  • Average Revenue over 5 years is $411000.0, with a median of -$324500.0 recorded in 2025.
  • Year-over-year, Revenue tumbled 45.67% in 2023 and then increased 24.69% in 2025.
  • Kezar Life Sciences' Revenue stood at -$159000.0 in 2021, then crashed by 71.07% to -$272000.0 in 2022, then soared by 2673.53% to $7.0 million in 2023, then crashed by 105.73% to -$401000.0 in 2024, then grew by 24.69% to -$302000.0 in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at -$302000.0, -$347000.0, and -$401000.0 for Q2 2025, Q1 2025, and Q2 2024 respectively.